TNX-102 SL was granted Fast Track designation for fibromyalgia by the FDA in July of 2024. Fast Track is designed to expedite FDA review of important new drugs to treat serious conditions and fill ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback